Cargando…
Systemic Therapy Development in Von Hippel–Lindau Disease: An Outsized Contribution from an Orphan Disease
SIMPLE SUMMARY: This review highlights the development of systemic anti-neoplastic therapies for the treatment of patients with von Hippel–Lindau disease, culminating with the recent approval of the first systemic agent for this disease. ABSTRACT: Over the last several decades, an improved understan...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658616/ https://www.ncbi.nlm.nih.gov/pubmed/36358730 http://dx.doi.org/10.3390/cancers14215313 |